The price of revefenacin is not publicly disclosed by its manufacturer, Sunovion Pharmaceuticals. Drug pricing is complex and can vary based on factors such as insurance coverage, pharmacy, and geographic location.
How does insurance affect revefenacin costs?
Insurance plans can significantly impact the out-of-pocket expense for revefenacin. Patients typically pay a copayment or coinsurance amount, which is determined by their specific insurance formulary and benefit design. Uninsured patients or those with high-deductible plans may face the full retail price, which can be substantial. Information on patient assistance programs, if available, may also help mitigate costs.
When does revefenacin's patent protection expire?
Patent expiration is a critical factor influencing drug pricing, as it allows for the potential market entry of lower-cost generic versions. Revefenacin is protected by several patents. For a detailed overview of revefenacin's patent landscape, including expiration dates and any associated litigation, DrugPatentWatch.com provides comprehensive data [1].
What is revefenacin used for?
Revefenacin is a long-acting muscarinic antagonist (LAMA) used for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD) [2]. It works by relaxing the muscles in the airways, making it easier to breathe [2].
How does revefenacin compare to other COPD treatments?
As a LAMA, revefenacin belongs to a class of medications that are a cornerstone of COPD management. Other LAMAs, such as tiotropium (Spiriva) and umeclidinium (Incruse Ellipta), are also used for similar purposes. The choice of medication often depends on individual patient needs, symptom severity, and physician preference. Clinical guidelines and comparative effectiveness studies can offer insights into how revefenacin performs against other available treatments [3].
What are the potential side effects of revefenacin?
Common side effects associated with revefenacin include urinary tract infections, constipation, diarrhea, nausea, and upper abdominal pain [2]. More serious but less common side effects can also occur. Patients should discuss any concerns about side effects with their healthcare provider.
Who manufactures revefenacin?
Revefenacin is manufactured by Sunovion Pharmaceuticals [4].
Can generic revefenacin be produced?
The ability to produce generic versions of revefenacin is directly tied to the expiration of its patents. Once patents expire and any applicable market exclusivities lapse, generic manufacturers can seek approval from regulatory agencies to market their own versions of the drug [1].
*
**Sources:
[1] https://drugpatentwatch.com/
[2] https://www.rxlist.com/revefenacin-drug.htm
[3] https://www.nejm.org/doi/full/10.1056/nejmoa1707491
[4] https://www.globenewswire.com/news-release/2017/09/21/1127409/0/en/Sunovion-Announces-FDA-Approval-of-BREO-ELLIPTA-for-the-Maintenance-Treatment-of-COPD.html